Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check5 days agoChange DetectedExternal informational links to MedlinePlus, NIH/NLM/NCBI, MSKCC, and government sites were removed from the page. These links were supplementary and not part of the core study details.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedCore content updated with an operational status notice and a new version (v3.2.0); previous version (v3.1.0) removed.SummaryDifference3%

- Check41 days agoChange DetectedMajor contact/name and metadata updates: old contact David Pfister, MD and older revision/date replaced with Eric Sherman, MD and new contact numbers, plus updated last-update and revision version.SummaryDifference1%

- Check55 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing specific geographic details and certain drug information.SummaryDifference2%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.